Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bausch Health Companies Inc

6.38
+0.18002.90%
Post-market: 6.400.0191+0.30%18:55 EDT
Volume:3.07M
Turnover:19.50M
Market Cap:2.36B
PE:-58.81
High:6.43
Open:6.21
Low:6.20
Close:6.20
Loading ...

Top Analyst Reports for Exxon Mobil, Netflix & Alibaba

Zacks
·
12 Mar

Bausch Health Companies Inc. (BHC): Among Top Stock Picks From Carl Icahn’s Portfolio

Insider Monkey
·
02 Mar

Is Bausch Health Companies Inc. (BHC) the Best Low Price Pharma Stock to Invest In Right Now?

Insider Monkey
·
27 Feb

Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), Evolent Health (EVH) and Bausch Health Companies (BHC)

TIPRANKS
·
21 Feb

Bausch Health Companies Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
21 Feb

3 US Growth Companies With Up To 28% Insider Ownership

Simply Wall St.
·
21 Feb

Bausch Health: Navigating Market Risks Amid Uncertain Product Acceptance

TIPRANKS
·
21 Feb

Why Bausch Health Companies Inc. (BHC) Went Up On Thursday?

Insider Monkey
·
21 Feb

Stock Track | Bausch Health Soars 11.52% Pre-Market on Strong Q4 Results, Robust Innovation Pipeline

Stock Track
·
20 Feb

Stock Track | Bausch Health Soars 5% Pre-Market on Strong Outlook and Innovation Pipeline

Stock Track
·
20 Feb

Bausch Health Companies (BHC) Gets a Hold from Truist Financial

TIPRANKS
·
20 Feb

Q4 2024 Bausch + Lomb Corp Earnings Call

Thomson Reuters StreetEvents
·
20 Feb

Compared to Estimates, Bausch (BHC) Q4 Earnings: A Look at Key Metrics

Zacks
·
20 Feb

Bausch Health Swings to Q4 Profit, Revenue Increases -- Shares Rise After Hours

MT Newswires Live
·
20 Feb

Bausch Health Shares Climb On Better-Than-Expected Q4 Revenue, Strong Forward Guidance

Benzinga
·
20 Feb

Stock Track | Bausch Health Companies Stock Soars 5.99% in After-Hours on Solid Q4 Results and Growth Outlook

Stock Track
·
20 Feb

Bausch Health Companies Q4 Sales $2.56B Beat $2.52B Estimate

Benzinga
·
20 Feb

Bausch Health Announces Fourth Quarter and Full-Year 2024 Results

ACCESS Newswire
·
20 Feb

Bausch Health options imply 7.8% move in share price post-earnings

TIPRANKS
·
20 Feb

Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent

Yahoo Finance
·
19 Feb